162 related articles for article (PubMed ID: 16088954)
1. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
2. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3.
Lee NE; Reddy GS; Brown AJ; Williard PG
Biochemistry; 1997 Aug; 36(31):9429-37. PubMed ID: 9235987
[TBL] [Abstract][Full Text] [Related]
4. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia.
Cohen R; Johnson K; Humes HD
Miner Electrolyte Metab; 1988; 14(2-3):121-8. PubMed ID: 3380067
[TBL] [Abstract][Full Text] [Related]
7. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
Siu-Caldera ML; Sekimoto H; Peleg S; Nguyen C; Kissmeyer AM; Binderup L; Weiskopf A; Vouros P; Uskoković MR; Reddy GS
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):111-21. PubMed ID: 10659699
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1alpha,25-dihydroxyvitamin D3 in rats.
Sekimoto H; Siu-Caldera ML; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Uskokovic MR; Reddy GS
FEBS Lett; 1999 Apr; 448(2-3):278-82. PubMed ID: 10218492
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney.
Weinstein EA; Rao DS; Siu-Caldera ML; Tserng KY; Uskokovic MR; Ishizuka S; Reddy GS
Biochem Pharmacol; 1999 Dec; 58(12):1965-73. PubMed ID: 10591152
[TBL] [Abstract][Full Text] [Related]
10. [1 alpha-hydroxyvitamin D3: chemical synthesis and biological effect].
Bauman VK; Bogoslovskiĭ NA; Kisel'nikova TA; Shakhova MK; Valinietse MIu
Prikl Biokhim Mikrobiol; 1978; 14(2):243-52. PubMed ID: 208064
[TBL] [Abstract][Full Text] [Related]
11. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
[TBL] [Abstract][Full Text] [Related]
13. Physiological significance of C-28 hydroxylation in the metabolism of 1alpha,25-dihydroxyvitamin D(2).
Rao DS; Siu-Caldera ML; Uskokovic MR; Horst RL; Reddy GS
Arch Biochem Biophys; 1999 Aug; 368(2):319-28. PubMed ID: 10441383
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 1alpha,25-dihydroxyvitamin D(3) and its C-3 epimer 1alpha,25-dihydroxy-3-epi-vitamin D(3) in neonatal human keratinocytes.
Reddy GS; Muralidharan KR; Okamura WH; Tserng KY; McLane JA
Steroids; 2001; 66(3-5):441-50. PubMed ID: 11179753
[TBL] [Abstract][Full Text] [Related]
15. On the mechanisms for the selective action of vitamin D analogs.
Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 metabolites in hypercalcaemic adults after kidney transplantation.
Lucas PA; Brown RC; Bloodworth L; Woodhead JS
Proc Eur Dial Transplant Assoc; 1983; 20():213-9. PubMed ID: 6318219
[TBL] [Abstract][Full Text] [Related]
17. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
Wong RG; Norman AW; Reddy CR; Coburn JW
J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
[TBL] [Abstract][Full Text] [Related]
18. Influence of zinc and calcium deficiency on the concentrations of calcitonin, parathyroid hormone, and 25-hydroxy-vitamin D3 in rat serum.
Roth HP; Kirchgessner M
J Trace Elem Electrolytes Health Dis; 1989 Dec; 3(4):225-30. PubMed ID: 2535346
[TBL] [Abstract][Full Text] [Related]
19. The photobiogenesis and metabolism of vitamin D.
Holick MF; Clark MB
Fed Proc; 1978 Oct; 37(12):2567-74. PubMed ID: 212325
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Finch JL; Brown AJ; Slatopolsky E
J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
